WHY BELIEVE IN COMMPASS?
- CoMMpass is an exciting new 10-year clinical study in multiple myeloma
- CoMMpass is helping researchers gain access to each patient's genetic analysis to help them learn how patients respond to therapies
- CoMMpass is a collaboration of world-class researchers and institutions, a dream team of cancer specialists
- CoMMpass is backed by 50 leading cancer centers, multinational pharmaceutical firms, and millions of dollars in funding
WHY DOES COMMPASS NEED ME?
CoMMpass must enroll 1000 multiple myeloma patients—and we're not quite there yet.
By participating in CoMMpass, patients will help accelerate the discovery and development of precision medicine for multiple myeloma.
WHY CALL TODAY?
CoMMpass is for newly diagnosed patients only. Once you've had your first treatment, you're no longer eligible. In other words, there's no time to waste.
Information for Clinicians »
Watch Videos about CoMMpass »
Read News Articles about CoMMpass »
Stand with the MMRF.
Enroll in CoMMpass today.